Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.
A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.
People struggling with treatment-resistant PTSD may soon have a new course of care: MDMA. When used alongside psychotherapy, the synthetic substance in...